In vitro propagation and field
cultivation of Baptisia tinctoria
(L.) R. Br., a new field crop
Carolin Grotkass1, Imke Hutter1, Götz Harnischfeger2 and
Reinhard Lieberei3
1 InstitutE For Plant Cultivation, Solkau 2, 29465 Schnega,
Germany
2 Schaper & Brümmer GmbH & Co. KG, Bahnhofstr. 35,
38531 Salzgitter, Germany
3 Institute of Applied Botany, University of Hamburg, Marseillerstr. 7, 20355 Hamburg, Germany
The
use of Baptisia tinctoria roots and
rhizomes in traditional medicine is well known, today the drug is an ingredient
in immunomodulating pharmaceuticals, e.g. ESBERITOX® Schaper
& Brümmer. The drug is still being collected from its natural habitat in
the US with the risk of diverse quality and possible falsification with related
species. It was therefore prudent to establish an agricultural method for
obtaining high quality material.
Traditional
cultivation from seeds proved impractical due to their hardseededness and low
germination rate. Therefore, in vitro
propagation of plants had to be established. Seeds were collected from plants
with high quality properties among the wild endemic plant population of Ohio/USA.
They were scarified, surface sterilized and brought to germination within a
week. From the plantlets subsequently obtained meristem cultures were prepared
using stem cuts. Using this approach, mass propagation was established at an
industrial scale. It is possible and actually done to produce large quantities
of plantlets from a collection of elite-clones. The adaptation of the plantlets
from in vitro to greenhouse
conditions proved difficult. However, it was possible to improve the survival
rate considerably over the last few years. Plantlets are now transferred to the
greenhouse in March were they are held at high humidity and appropriate
temperature. One of the selection parameters used at this stage of
acclimatization is mildew resistance. The adapted plantlets are then
transferred to the fields in May and cultivated for three years. Currently
about 8-10 hectares are grown with Baptisia
tinctoria according to GAP rules (´Good Agricultural Practice for medicinal
and aromatic Plant Production´).
Since
the in vitro culture, the in vitro/ex vitro adaptation procedure and the field cultivation have now
been established, the main aspect of ongoing work is the selection and
propagation of high performance clones leading to large yields of high quality
drug.
Poster
IAPTC, Jerusalem, 14.-19.6.1998